# US 2020/0392107 A1 · Cyclic amine derivative and medical use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0392107 A1
- Document ID: US20200392107A1
- Status: Published application
- Kind: A1
- Application number: 16/960,422
- Filed: 2019-01-30
- Published: 2020-12-17
- Earliest claimed: 2018-01-31
- Assignees: Toray Industries, Inc.
- Applicants: Toray Industries, Inc.
- Inventors: Kazuya Osumi; Yuki Matsumura; Shinnosuke Hayashi; Masaki Hoshi; Martial Vallet; Shinya Yokosaka; Takumi Aoki; Hiroyuki Meguro; Mie Kaino; Kozuc Takagaki; Rie Sasaki
- Web page: https://patentgrep.com/patent/US20200392107A1

## CPC

- C07D 401/12: linked by a chain containing hetero atoms as chain links
- A61K 9/7023: {Transdermal patches and similar drug-containing composite devices, e.g. cataplasms (galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006)}
- A61P 17/04: Antipruritics
- A61P 17/06: Antipsoriatics
- A61P 17/14: for baldness or alopecia
- A61P 37/02: Immunomodulators
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A cyclic amine derivative represented by general Formula (I): wherein R1 represents an alkyl group having 1 to 3 carbon atoms; A represents a group represented by general Formula (II-1), (II-2), or (II-3): R2 represents a hydrogen atom or a halogen atom; R3 represents an aryl group or a cycloalkyl group having 4 to 6 carbon atoms, wherein any 1 or 2 hydrogen atoms of the aryl or cycloalkyl group represented by R3 may be each independently substituted with an alkyl group having 1 to 3 carbon atoms or an alkyloxy group having 1 to 3 carbon atoms, and wherein any 1 to 3 hydrogen atoms of the alkyl or alkyloxy group having 1 to 3 carbon atoms which can be a substituent of the aryl or cycloalkyl group may be each independently substituted with a halogen atom; n represents 1 or 2; or a pharmacologically acceptable salt thereof.

## Claims

### Claim at position 1

1-11. (canceled)

### Claim 12

A cyclic amine derivative represented by general Formula (I):
wherein
R1 represents an alkyl group having 1 to 3 carbon atoms;
A represents a group represented by general Formula (II-1), (II-2), or (II-3):
R2 represents a hydrogen atom or a halogen atom;
R3 represents an aryl group or a cycloalkyl group having 4 to 6 carbon atoms, wherein any 1 or 2 hydrogen atoms of the aryl or cycloalkyl group represented by R3 may be each independently substituted with an alkyl group having 1 to 3 carbon atoms or an alkyloxy group having 1 to 3 carbon atoms, and wherein any 1 to 3 hydrogen atoms of the alkyl or alkyloxy group having 1 to 3 carbon atoms which can be a substituent of the aryl or cycloalkyl group may be each independently substituted with a halogen atom;
n represents 1 or 2;
a wavy line represents the point of attachment to general Formula (I),
or a pharmacologically acceptable salt thereof.

### Claim 13 (depends on 12)

The cyclic amine derivative according to claim 12, wherein:
R2 is a hydrogen atom, a fluorine atom, or a chlorine atom; and
R3 is an aryl group or a cycloalkyl group having 4 to 6 carbon atoms, wherein any 1 or 2 hydrogen atoms of the aryl or cycloalkyl group represented by R3 may be each independently substituted with a methyl group or a methoxy group, and wherein any 1 to 3 hydrogen atoms of the methyl or methoxy group which can be a substituent of the aryl or cycloalkyl group may be each independently substituted with a fluorine atom or a chlorine atom,
or a pharmacologically acceptable salt thereof.

### Claim 14 (depends on 12)

The cyclic amine derivative according to claim 12, wherein:
R2 is a fluorine atom or a chlorine atom;
R3 is a phenyl group or a cyclohexyl group, wherein any 1 or 2 hydrogen atoms of the phenyl or cyclohexyl group represented by R3 may be each independently substituted with a methyl group or a methoxy group, and wherein any 1 to 3 hydrogen atoms of the methyl or methoxy group which can be a substituent of the phenyl or cyclohexyl group may be each independently substituted with a fluorine atom or a chlorine atom; and
n is 1,
or a pharmacologically acceptable salt thereof.

### Claim 15 (depends on 12)

The cyclic amine derivative according to claim 12, wherein:
R1 is a methyl group;
A is a group represented by general Formula (II-1) or (II-2):
R2 is a chlorine atom;
R3 is a phenyl group or a cyclohexyl group, wherein any 1 hydrogen atom of the phenyl or cyclohexyl group represented by R3 may be each independently substituted with a trifluoromethyl group or a trifluoromethoxy group;
n is 1; and
a wavy line represents the point of attachment to general Formula (I),
or a pharmacologically acceptable salt thereof.

### Claim 16 (depends on 12)

A medicament comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.

### Claim 17 (depends on 12)

A retinoid-related orphan receptor γ antagonist, comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.

### Claim 18 (depends on 12)

A therapeutic agent or preventive agent for an autoimmune disease, comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.

### Claim 19 (depends on 12)

A therapeutic agent or preventive agent for psoriasis or alopecia areata, comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.

### Claim 20 (depends on 12)

A therapeutic agent or preventive agent for an allergic disease, comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.

### Claim 21 (depends on 12)

A therapeutic agent or preventive agent for allergic dermatitis, comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.

### Claim 22 (depends on 12)

A therapeutic agent or preventive agent for contact dermatitis or atopic dermatitis, comprising the cyclic amine derivative according to claim 12 or a pharmacologically acceptable salt thereof as an active ingredient.
